Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, Single-center Clinical Trial to Evaluate the 4-valent HPV Vaccine for the Treatment and Prevention of Recurrent Respiratory Papillomatosis in Children

NCT01995721 is registered in ClinicalTrials.gov with National Institute of Child Health, Hungary as lead sponsor.

NCT NCT01995721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01995721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, Single-center Clinical Trial to Evaluate the 4-valent HPV Vaccine for the Treatment and Prevention of Recurrent Respiratory Papillomatosis in Children
Lead sponsor
National Institute of Child Health, Hungary
Phase
Phase 3
Overall status
Unknown status
Start date
February 28, 2014
Completion date
February 28, 2017
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent respiratory papillomatosis